501 related articles for article (PubMed ID: 23627137)
1. [Preparation of sustained release microspheres containing oxymatrine and their release characteristics in vitro].
Miao Y; Shen XC; Xiao CD; Wu LF; Zhou X; Tao L
Zhong Yao Cai; 2012 Oct; 35(10):1674-9. PubMed ID: 23627137
[TBL] [Abstract][Full Text] [Related]
2. Sophoridine-loaded PLGA microspheres for lung targeting: preparation, in vitro, and in vivo evaluation.
Wang W; Cai Y; Zhang G; Liu Y; Sui H; Park K; Wang H
Drug Deliv; 2016 Nov; 23(9):3674-3680. PubMed ID: 27689622
[TBL] [Abstract][Full Text] [Related]
3. Preparation and in vitro characterization of vascular endothelial growth factor (VEGF)-loaded poly(D,L-lactic-co-glycolic acid) microspheres using a double emulsion/solvent evaporation technique.
Karal-Yılmaz O; Serhatlı M; Baysal K; Baysal BM
J Microencapsul; 2011; 28(1):46-54. PubMed ID: 21171816
[TBL] [Abstract][Full Text] [Related]
4. Water-soluble betamethasone-loaded poly(lactide-co-glycolide) hollow microparticles as a sustained release dosage form.
Chaw CS; Yang YY; Lim IJ; Phan TT
J Microencapsul; 2003; 20(3):349-59. PubMed ID: 12881115
[TBL] [Abstract][Full Text] [Related]
5. Enhanced encapsulation and bioavailability of breviscapine in PLGA microparticles by nanocrystal and water-soluble polymer template techniques.
Wang H; Zhang G; Ma X; Liu Y; Feng J; Park K; Wang W
Eur J Pharm Biopharm; 2017 Jun; 115():177-185. PubMed ID: 28263795
[TBL] [Abstract][Full Text] [Related]
6. Preparation and characterization of negatively charged poly(lactic-co-glycolic acid) microspheres.
Xu Q; Crossley A; Czernuszka J
J Pharm Sci; 2009 Jul; 98(7):2377-89. PubMed ID: 19009589
[TBL] [Abstract][Full Text] [Related]
7. Sustained release of calcium hydroxide from poly(DL-lactide-co-glycolide) acid microspheres for apexification.
Cerda-Cristerna BI; Breceda-Leija A; Méndez-González V; Chavarría-Bolaños D; Flores-Reyes H; Garrocho-Rangel A; Komabayashi T; Wadajkar AS; Pozos-Guillén AJ
Odontology; 2016 Sep; 104(3):318-23. PubMed ID: 26175086
[TBL] [Abstract][Full Text] [Related]
8. Double-walled microspheres loaded with meglumine antimoniate: preparation, characterization and in vitro release study.
Navaei A; Rasoolian M; Momeni A; Emami S; Rafienia M
Drug Dev Ind Pharm; 2014 Jun; 40(6):701-10. PubMed ID: 23594302
[TBL] [Abstract][Full Text] [Related]
9. Development of a novel morphological paclitaxel-loaded PLGA microspheres for effective cancer therapy: in vitro and in vivo evaluations.
Zhang Z; Wang X; Li B; Hou Y; Yang J; Yi L
Drug Deliv; 2018 Nov; 25(1):166-177. PubMed ID: 29299936
[TBL] [Abstract][Full Text] [Related]
10. Protein encapsulation and release from poly(lactide-co-glycolide) microspheres: effect of the protein and polymer properties and of the co-encapsulation of surfactants.
Blanco D; Alonso MJ
Eur J Pharm Biopharm; 1998 May; 45(3):285-94. PubMed ID: 9653633
[TBL] [Abstract][Full Text] [Related]
11. Effects of process and formulation parameters on characteristics and internal morphology of poly(d,l-lactide-co-glycolide) microspheres formed by the solvent evaporation method.
Mao S; Shi Y; Li L; Xu J; Schaper A; Kissel T
Eur J Pharm Biopharm; 2008 Feb; 68(2):214-23. PubMed ID: 17651954
[TBL] [Abstract][Full Text] [Related]
12. Factors affecting the loading efficiency of water-soluble drugs in PLGA microspheres.
Ito F; Fujimori H; Makino K
Colloids Surf B Biointerfaces; 2008 Jan; 61(1):25-9. PubMed ID: 17719753
[TBL] [Abstract][Full Text] [Related]
13. Microencapsulation of ovalbumin in poly(lactide-co-glycolide) by an oil-in-oil (o/o) solvent evaporation method.
Uchida T; Yagi A; Oda Y; Goto S
J Microencapsul; 1996; 13(5):509-18. PubMed ID: 8864988
[TBL] [Abstract][Full Text] [Related]
14. Preparation and in vitro study of hydrochloric norvancomycin encapsulated poly (d,l-lactide-co-glycolide, PLGA) microspheres for potential use in osteomyelitis.
Yang H; Hao Y; Liu Q; Mi Z; Wang Z; Zhu L; Feng Q; Hu N
Artif Cells Nanomed Biotechnol; 2017 Nov; 45(7):1326-1330. PubMed ID: 27776425
[TBL] [Abstract][Full Text] [Related]
15. [Effect of preparation technique on in vitro release mechanism of huperzine A microspheres].
Fu XD; Gao YL; Ping QN
Yao Xue Xue Bao; 2006 Jul; 41(7):589-94. PubMed ID: 17007348
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and Characterization of PLGA Shell Microcapsules Containing Aqueous Cores Prepared by Internal Phase Separation.
Abulateefeh SR; Alkilany AM
AAPS PharmSciTech; 2016 Aug; 17(4):891-7. PubMed ID: 26416284
[TBL] [Abstract][Full Text] [Related]
17. Effects of material hydrophobicity on physical properties of polymeric microspheres formed by double emulsion process.
Ruan G; Feng SS; Li QT
J Control Release; 2002 Dec; 84(3):151-60. PubMed ID: 12468218
[TBL] [Abstract][Full Text] [Related]
18. Effects of formulation parameters on encapsulation efficiency and release behavior of thienorphine loaded PLGA microspheres.
Yang Y; Gao Y; Mei X
Pharm Dev Technol; 2013; 18(5):1169-74. PubMed ID: 21967467
[TBL] [Abstract][Full Text] [Related]
19. High loading efficiency and sustained release of siRNA encapsulated in PLGA nanoparticles: quality by design optimization and characterization.
Cun D; Jensen DK; Maltesen MJ; Bunker M; Whiteside P; Scurr D; Foged C; Nielsen HM
Eur J Pharm Biopharm; 2011 Jan; 77(1):26-35. PubMed ID: 21093589
[TBL] [Abstract][Full Text] [Related]
20. Enhanced gentamicin loading and release of PLGA and PLHMGA microspheres by varying the formulation parameters.
Chaisri W; Ghassemi AH; Hennink WE; Okonogi S
Colloids Surf B Biointerfaces; 2011 Jun; 84(2):508-14. PubMed ID: 21353499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
